VSTM2L and neoplasm: VSTM2L was significantly downregulated in tumor compared to normal tissues in GSE87211 (Figure 1(b)) and upregulated significantly in tumor tissues of nonresponders to pCRT in the GSE45404 and GSE68204 datasets (Figures 1(c) and 1(d)).